Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Dec 2012 07:25

AMEC: Credit Suisse reduces target price from 1300p to 1250p reiterating an outperform rating.Anglo American: Barclays upgrades to equal-weight with a target price of 1970p.Ashtead Group: Barclays raises target price from 352p to 434p and reiterates an overweight rating.ASOS: HSBC raises target price from 2590p to 2750p and keeps a neutral rating. Barclays raises target price from 3000p to 3100p maintaining an overweight rating.AstraZaneca: Deutsche Bank raises target price from 2880p to 2970p; hold rating remains unchanged.BAE Systems: Deutsche Bank moves target price from 340p to 350p reiterating a buy recommendation.Cookson Group: Citigroup downgrades to neutral with a target price of 650p.Diageo: Barclays reduces target price from 2050p to 2020p keeping its overweight rating. Nomura cuts target price from 2100p to 2070p and reiterates its buy recommendation.GlaxoSmithKline: Deutsche Bank moves target price from 1400p to 1440p and maintains a hold recommendation. Panmure Gordon raises target price from 1450p to 1500p and upgrades from hold to buy. Credit Suisse moves target price from 1430p to 1420p keeping a neutral rating.ICAP: Credit Suisse reduces target price from 350p to 320p and downgrades from outperform to neutral.IDOX: Investec raises target price from 47p to 60p and keeps its buy recommendation.IG Group: UBS cuts target price from 525p to 505p; buy rating kept.Lonmin: Credit Suisse upgrades to outperform with an target price of 525p.Meggitt: Deutsche Bank raises target price from 425p to 445p; buy recommendation unchanged.Mothercare: UBS raises target price from 230p to 250p and retains a sell recommendation.Redefine International: Peel Hunt downgrades to hold.Rolls-Royce Group: Deutsche Bank raises target price from 790p to 870p and keeps a hold recommendation.Senior: Jefferies moves target price from 233p to 236p, while keeping a buy recommendation.Shire Pharmaceuticals: Credit Suisse raises target price from 2180p to 2250p and keeps an outperform rating.Stratex International: Northland Capital reduces target price from 17.10p to 12.80p maintaining its buy recommendation.TUI Travel: Alphavalue raises target price from 260.30p to 346.40p and upgrades to buy.Tullow Oil: UBS cuts target price from 1400p to 1250p and keeps a neutral rating. Deutsche Bank reduces target price from 1180p to 1155p reiterating a hold recommendation. Barclays cuts target price from 1895p to 1845p, while maintaining an overweight rating. Credit Suisse reduces target price from 1550p to 1480p and downgrades from outperform to neutral. WH Ireland reduces target price from 1592p to 1515p, while keeping its buy recommendation. Liberum Capital moves target price from 1800p to 1760p and retains a buy rating.Ultra Electronics Holdings: Deutsche Bank downgrades to sell, while retaining target price at 1400p.Unilever: UBS raises target price from 2400p to 2590p, while maintaining its buy recommendation.Victrex: JP Morgan raises target price from 1160p to 1500p keeping a neutral rating. HB Markets upgrades to buy.Whitbread: JP Morgan raises target price from 2500p to 2650p; overweight rating remains unchanged.WPP Group: JP Morgan raises target price from 1004p to 1054p and retains an overweight rating.
More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.